Exclusion Criteria:
- Participants who have been a recipient of prior allogeneic stem cell/progenitor cell therapy for any indication or autologous stem cell/progenitor cell therapy or other biological intervention to repair the index intervertebral disc.
- Participants with low back pain duration of less than 6 months or greater than 60 months.
The reduction in low back pain observed in all subjects was substantially enhanced in the prespecified population with CLBP of shorter duration than the median of 68 months for the study
(n=194)
Reg
2024 Here we go again., page-237
-
- There are more pages in this discussion • 707 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
-0.010(1.03%) |
Mkt cap ! $1.121B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.0¢ | $2.150M | 2.202M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2025 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.5¢ | 7682 | 1 |
View Market Depth
| Last trade - 15.59pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |